✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Bharat Parenterals Ltd.

BPLPHARMA

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹1,048 Cr.
P/E
0.00

Bharat Parenterals Ltd.

  • Bharat Parenterals
  • Lincoln Pharma
  • Anuh Pharma
  • TJI Pharma - Small Cap
FAQs on Bharat Parenterals Ltd. Shareprice

Bharat Parenterals has given better returns compared to its competitors.
Bharat Parenterals has grown at ~41.45% over the last 7yrs while peers have grown at a median rate of 13.46%

Bharat Parenterals is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Bharat Parenterals is 0.0, while 3 year average PE is 18.26.
Also latest EV/EBITDA of Bharat Parenterals is 97.47 while 3yr average is 81.48.

View FAQ's On Business
Growth Table
  • Bharat Parenterals Ltd.
  • Lincoln Pharma
  • Anuh Pharma
Balance Sheet
  • Bharat Parenterals Ltd.
  • Lincoln Pharma
  • Anuh Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Bharat Parenterals Ltd.
  • Lincoln Pharma
  • Anuh Pharma
Cash Flow
  • Bharat Parenterals Ltd.
  • Lincoln Pharma
  • Anuh Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Bharat Parenterals Ltd.
  • Lincoln Pharma
  • Anuh Pharma
Quarterly Results
  • Bharat Parenterals Ltd.
  • Lincoln Pharma
  • Anuh Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Bharat Parenterals Ltd. Financials

Balance sheet of Bharat Parenterals is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Bharat Parenterals is decreasing.
Latest net debt of Bharat Parenterals is ₹123 Crs as of Mar-25.
This is less than Mar-24 when it was ₹133 Crs.

No, profit is decreasing.
The profit of Bharat Parenterals is -₹35.7 Crs for TTM, ₹14.52 Crs for Mar 2024 and ₹16.4 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Bharat Parenterals latest dividend payout ratio is 4.01% and 3yr average dividend payout ratio is 3.32%

Companies resources are allocated to majorly productive assets like Plant & Machinery

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech